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Summary The uptake of myristic (C14:0), palmitic (C16:0), palmitoleic (C:16,N-7), stearic (C18:0), oleic
(C18:1,N-9), linoleic (C18:2,N-6) and arachidonic (C20:4,N-6) acids from plasma free fatty acids (FFA),
triglycerides (TGA), phospholipids (PL) and cholesterol esters (CE) was measured in tissue-isolated hepatomas
7288CTC and 7777 in vivo. Adult tumour-bearing Buffalo rats were fed a normal chow diet ad libitum and
were subjected to darkness from 1800 to 0600 h. Arterial plasma levels of FFA, TGA, PL and CE were
increased during the dark period without change in fatty acid compositions. Arteriovenous difference
measurements of tumour lipid uptake were performed between 0600 and 0900 h and included both high (dark)
and low (light) arterial blood lipid concentrations. The rate of lipid uptake from each lipid class was directly
dependent on the rate of supply of the lipid to the tumour. The efficiency ofuptake, however, depended on the
type of plasma lipid and the tumour. During one pass of arterial blood, hepatoma 7288CTC (n = 5 to 13)
removed 46, 33, 36 and 31%, and hepatoma 7777 (n = 7 to 9) removed 48, 50, 52 and 49% of the fatty acids
supplied in FFA, TGA, PL and CE, respectively. Perfusion of tissue-isolated tumours in situ with donor blood
containing plasma free (1-'4C)palmitic acid showed that '4C-palmitic acid was removed from the arterial blood
and was incorporated into tumour lipids and that '4CO2 was released into the tumour venous blood. Uptake
of the seven fatty acids over a 24 h period was greatest from PL>TGA> FFA> CE and was estimated to
total 18.1 ± 3.5 mg fatty acids g-' for hepatoma 7288CTC and 25.9 ± 3.5 mg fatty acids g-' for hepatoma
7777. Both hepatoma 7288CTC and 7777 grew at a rate of about 1 gday-' and contained 13.4 ± 2.5 and
10.6 ± 3.9 mg of these 7 fatty acids g-' tumour wet weight, respectively. We conclude that these two tumours
obtain all of the fatty acids needed for daily growth from host arterial blood.
Experiments performed in vivo with tissue-isolated rat
tumours (Gullino & Grantham, 1961; Sauer et al., 1982) and
with human tumour xenografts growing in nude rats (Steinau
et al., 1981) have demonstrated that solid tumours have a
large capacity for uptake of host nutrients. Thirty to 40% of
the glucose (Gullino et al., 1967; Sauer et al., 1982; Sauer &
Dauchy, 1983; Kallinowski et al., 1988), ketone bodies (Sauer
& Dauchy, 1983; Kallinowski et al., 1988) and amino acids
(Sauer et al., 1982) contained in arterial blood was removed
during one pass through the tumour. The rates of nutrient
uptake were directly dependent on the rates of supply and
were not saturable at normal physiological blood concentra-
tions (Sauer et al., 1982; Kallinowski et al., 1988). Arterial
blood also transports lipid nutrients, including free fatty
acids (FFA) and lipoproteins that contain triglycerides
(TGA), phospholipids (PL) and cholesterol esters (CE). Solid
tumours, especially those that are fast-growing and
undifferentiated, are thought to have a diminished ability to
synthesise fatty acids (Weber et al., 1961) and, therefore, to
obtain some or all of the lipids required for growth and
metabolism from host sources. Tumours release lipolytic pep-
tides that promote mobilisation of host lipid stores (Beck &
Tisdale, 1987; 1991). Possibly, the function of the lipolytic
agent is to increase the lipid supply to the tumour, including
the essential fatty acids, which may have a stimulative effect
on tumour growth (Sauer & Dauchy, 1988). Relationships
between lipid supply in the arterial blood, tumour uptake
and requirements for growth have not yet been investigated
in solid tumours in vivo. In this study we measured uptake of
seven fatty acids from plasma FFA, TGA, PL, and CE in
tissue-isolated hepatomas 7288CTC and 7777. Total tumour
fatty acid uptake was estimated for a 24 h period and was
compared to the daily increment in tumour lipid content due
to growth.
Materials and methods
Reagents
Hepatane (HPLC) grade, chloroform, methanol and ethanol
were obtained from Fisher Chemical Co., Pittsburgh, PA.
Heptane and chloroform were redistilled before use. Methyl
esters of rapeseed oil fatty acids, standard FFAs and boron
triflouride-methanol reagent were purchased from Supelco,
Bellefonte, PA and from Sigma Chemical Co. St. Louis, MO.
'4C-Palmitic acid (1-4C, 56mCi mmol-') was purchased from
NEN Research Products, Boston, MA. Butylated hydroxy-
toluene was obtained from Sigma Chemical Co.
Animals and diets
The male and female Buffalo rats used in these experiments
were obtained from colonies established here. Animals were
maintained at 23°C in a 12 h light/dark cycle. Breeding pairs,
pregnant females and experimental rats were fed a standard
laboratory diet (Prolab mouse, rat and hamster 1000 for-
mula; Agway, Inc., Syracuse, NY) and water ad libitum.
Lipid analyses performed on different batches of this diet
showed a mean fatty acid content of 39.2 mg g-1, which was
composed of 2.3% myristic (C14:0), 23.2% palmitic (C16:0),
2.8% palmitoleic (C16:1,N-7), 11.9% stearic (C18:0), 35.8%
oleic (C18:1,N-9), 21.2% linoleic (C18:2,N-6) and 0.1%
(arachidonic (C20:4,N-6) acids. Two additional unidentified
fatty acids comprised about 3%. Ninety-one percent of the
fatty acids was present as TGA and PL.
Tumour implantation andgrowth
All experiments were performed with Morris hepatomas
7288CTC or 7777 grown subcutaneously as tissue-isolated
tumours (Sauer et al., 1982). Briefly, a 3-mm cube of tumour
was attached to the end of a vascular stalk composed of the
truncated left superficial inferior epigastric artery and vein;
the femoral artery and vein distal to the sup. inf. epigastric
vessels were not ligated (Dauchy & Sauer, 1986). The tumour
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implant and vascular stalk were enclosed in a Paraffin
envelope (Gullino et al., 1961), placed in the inguinal fossa
with a drop of sterile penicillin G procaine suspension
(Wyeth Laboratories, Inc., Philadelphia, PA), and the skin
incision was closed. Arterial blood supply to and venous
drainage from the implant were established through the
epigastric vessels. Vascular connections to other host tissues
were blocked by the Paraffin envelope. Tumour weights in
vivo were estimated from measurements made through the
skin (Sauer et al., 1986).
Two male and three female tumour-bearing rats weighing
250 to 300 g were anticoagulated with warfarin for 4 to 9
days before tumour harvest. Pellets of normal diet and
Coumadin tablets (Du Pont Pharmaceuticals, Wilmington,
DE) were ground together to give a mixture that contained
1.25 ,Lg crystalline sodium warfarin g-' diet. Each rat ate 18
to 22 g of this diet for a dose of about 0.1 mgkg-' body
weight daily.
Collection ofarterial blood
Adult Buffalo rats bearing tissue-isolated hepatoma 7288CTC
or 7777 were anaesthetised by CO2 inhalation and blood was
collected by heart puncture. Samples were obtained from
groups of three to six rats at 2 h (FFA analysis) or 4 to 6 h
(TGA, PL and CE analyses) intervals for a total of 24 h.
Blood collection times were adjusted so that no animal was
sampled more frequently than once per day.
Arteriovenous difference measurements
Tissue-isolated hepatomas weighing 3.2 to 8 g (mean=
5.41 ± 0.96 g, n = 22) were prepared for arteriovenous differ-
ence measurements (Sauer et al., 1982) using the
modifications described by Dauchy & Sauer (1986). Host
carcass weights were 306 ± 42 g (n = 11) for male rats and
252 ± 14 g (n = 11) for female rats. All animals were anaes-
thesised with pentobarbital (25 mg kg-' body weight, IP) and
breathed air during the procedure. After exposure of the
tumour and tumour vasculature, the femoral artery and vein
distal to the tumour were ligated. The tumour was inspected
to determine that there were no vascular connections other
than the sup. inf. epigastric vessels and the host was
anticoagulated by injecting 200 units of sodium heparin into
the jugular vein. (Heparin injection was not necessary in
measurements made in warfarin-treated host rats.) A catheter
was placed in the left carotid artery and a butterfly catheter
(no. 4573, Abbott Hospitals, North Chicago, IL) was
inserted into the vein draining the tumour. Blood flowed
passively from the venous catheter; flow rates were calculated
from timed collections (Sauer et al., 1982). Arterial and
tumour venous blood samples (about 0.5 ml) were collected
simultaneously. The samples were immediately chilled in ice,
then centrifuged and the plasma removed and stored in ice in
capped tubes. Hematocrits were measured on blood obtained
directly from the arterial and tumour venous catheters.
Plasma protein contents were assayed using a biuret method.
Tumours were removed from the host rats, chilled in ice-
cold 0.15 M NaCl, cut in two and weighed. Three tumours
were hemorrhagic and were discarded. Tissue-isolated
tumours grown on the sup. inf. epigastric vessels generally
show only microscopic necrosis (Sauer et al., 1982). However,
a portion of the original tumour implant (3 mm cube) often
becomes necrotic. Since these necrotic volumes were small
and could not be easily removed without disaggregating the
tumour, they were included in the total tumour weight. A
portion of the tumour was minced, visibly necrotic fragments
were removed and a 20% homogenate (w/v) was prepared in
0.15 M NaCl containing 0.05% butylated hydroxytoluene. All
procedures were performed at 0 to 4°C.
Tumour substrate supply rates were calculated by multiply-
ing the arterial whole blood concentration by the arterial
blood flow rate and dividing by the tumour wet weight.
Outflow rates were calculated by multiplying the substrate
concentration in tumour venous whole blood by the tumour
venous blood flow rate and dividing by the tumour wet
weight. Since the total tumour wet weight included small
necrotic volumes, which presumably had no blood flow, these
supply and outflow rates may be slightly lower than the
actual rates. Uptake was the difference between supply and
outflow. Both supply and uptake rates have units of ,ug (or
mg) fatty acid min' g-' wet weight tumour. These units
were selected because the mass of fatty acid uptake is related
directly to the tumour mass. Molar quantities may be
obtained after division by the molecular weight of the fatty
acid.
Tumourperfusion in situ
Tissue-isolated hepatomas used for perfusion were implanted
and prepared for perfusion as described above. The femoral
artery and vein distal to the tumour were not ligated until
after insertion of the butterfly catheter into the tumour vein
and insertion of the arterial catheter (carrying the donor
blood perfusate) into the femoral-epigastric arterial trunk
leading to the tumour. When flow of donor blood was
established, the host was exsanguinated through the carotid
catheter. Temperature of the host body was monitored using
a rectal probe and maintained at 37'C with a heating pad
beneath and a heat lamp above the animal.
Arterial blood used for perfusion was collected from the
carotid arteries of adult, heparinised male or female rats fed
normal diet ad libitum. Donor rats were anaesthetised with
pentobarbital (25 mg kg-') before exsanguination. Pooled
donor blood was filtered through two layers of cheesecloth
and separated into plasma and cells by centrifugation.
Carrier-free '4C-palmitic acid (sufficient to give about 20,000
dpm ml-' reconstituted whole blood) was added to a plastic
tube and the solvent (ethanol) air dried. The donor plasma
was added and mixed by gentle stirring at 0'C for about
20 min. Small portions of the plasma were counted to deter-
mine entry of the labelled palmitic acid into the plasma. Cells
from the donor blood were added back, mixed, and the
suspension transferred to a plastic container immersed in ice
and stirred with a magnetic stirrer. The labelled whole blood
perfusate was pumped through the tumour with a peristaltic
pump (Harvard Apparatus, Natick, MA) at a setting
adjusted to give a flow rate from the tumour venous catheter
of about 0.12 ml min-'. The perfusate was warmed in a 37°C
water bath immediately before entering the tumour. pH,
PCO2 and PO2 in the arterial blood perfusate were main-
tained at about 7.4 and 40 and 100 mm Hg, respectively, by
gently blowing a water-saturated air-CO2 mixture over the
surface of the stirred perfusate. Measurements were made
using a blood gas analyser (Model 945, AVL, Graz, Austria).
Arterial blood samples were collected from a Y-tube connec-
tor located in the arterial catheter immediately before the
tumour.
The specific activity of '4C-palmitic acid in arterial and
tumour venous blood was determined by analysing and coun-
ting plasma FFA extracts. No radioactivity was found in any
other plasma lipid fraction. '4CO2 contained in arterial and
tumour venous blood was measured in closed flasks using
phenethylamine as trapping agent (Sauer et al., 1980). Incor-
poration of '4C-palmitic acid into tumour lipids was
measured in a total lipid extract and in a portion of tumour
solubilised in Protosol (NEN Research Products, Boston,
MA). Radioactivity was counted in a scintillation counter.
Addition of '4C-palmitic acid directly to the donor plasma
avoided addition of exogenous albumin (or other proteins)
that might either interfere with or modify tumour fatty acid
uptake. The exogenous '4C-palmitic acid in donor plasma
migrated with the albumin band during electrophoresis.
Lipid extraction andchromatography
FFAs were extracted from the arterial and tumour venous
plasma samples as previously described (Sauer & Dauchy,
1988). Heptadecanoic acid was used as an internal standard
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esters of the FFAs were formed using boron trifluoride-
methanol reagent. Arterial and tumour venous plasma TGA,
PL and CE were extracted from 0.2 ml of plasma by the
Folch method (Folch et al., 1957), using the procedure of
McDonald-Gibson (McDonald-Gibson, 1987). Internal stan-
dard, dissolved in chloroform, was added following the initial
mixing of the plasma sample with methanol and prior to the
addition ofchloroform. In some experiments the lipid extract
was separated by thin layer chromatography on silica gel G
plates (Redi-plates, Fisher Scientific, Pittsburgh, PA) that
were sprayed with Rhodamine B in ethanol and activated at
100°C. The solvent mixture was n-hexane:diethyl ether:
glacial acetic acid (80:20:2 by volume). Heptadecanoic acid,
tripentadecanoin, diheptadecanoyl phosphatidyl choline, and
cholesterol heptadecanoate were used as internal standards.
The total plasma lipid extract or the separated lipid classes
were saponified in methanolic-NaOH (0.5M) for 5 min at
100°C and the fatty acids methylated using boron triflouride-
methanol reagent for 2 min at 100TC. Fatty acid contents are
given as jig (or mg) ml-' whole blood or as percent of total
fatty acids. Molar concentrations are obtained after division
by the fatty acid molecular weight.
Tumour lipids were extracted from 0.25 ml of homogenate
and were analysed directly or were separated by thin layer
chromatography as described above. Homogenates were kept
at 0°C to slow hydrolysis of TGAs by tumour lipases. Fatty
acid contents are given as ytg (or mg) g'l tumour wet weight.
All gas chromatographic analyses of blood and tumour sam-
ples were performed in duplicate.
Fatty acid analysis
The fatty acid methyl esters were measured using a Hewlett-
Packard Model 5890A gas chromatograph equipped with a
flame-ionisation detector, an electronic integrator (Model
3396A) and autoinjector (Model 7673A). Separations were
performed with a 0.25 mm x 30 m capillary column (Model
2330, Supelco Inc., Bellefonte, PA) at 190°C with helium as
the carrier gas (linear gas rate: 19cmsec-'; split, 100:1).
Injection port and detector were at 220°C. Fatty acid methyl
esters were identified by their retention times compared to
known standards.
Statistical analysis
Means were presented ± ls.d. and were compared by
Student's t-test or by one-way analysis of variance and the
Duncan multiple range test. P<0.05 was considered
significant.
Results
Characteristics ofarterial and tumour venous blood
The plasma protein concentrations (53.3 ± 6.9 g 1`, n = 13)
and hematocrits (41.3 ± 4.9%, n = 21) of arterial blood were
increased during passage through hepatomas 7288CTC and
7777 in vivo and during perfusion in situ. Mean values for
plasma protein concentration and hematocrit in tumour
venous blood were 61.6 ± 7.3 g l- (P<0.01) and 46.9 ±
4.7% (P<0.01), respectively, indicating that about 15% of
arterial blood water was lost in one pass through the tumour.
The excess fluid was apparently drained away by lymphatic
vessels in the subcutaneous space. Arterial blood flow rates
were corrected for this fluid loss by multiplying the measured
tumour venous blood flow rates by the quotient of either the
tumour venous blood hematocrit/arterial blood hematocrit or
the tumour venous plasma protein concentration/arterial
blood plasma protein concentration. Calculated arterial
blood flow rates were 0.141 ± 0.01 mlmin-'; mean tumour
venous blood flow rates were 0.124 ± 0.01 (n = 22) and
ranged from 0.11 to 0.133 ml min-1 indicating the passive
flow from the venous catheter was reproducible from tumour
to tumour. Total blood flow in these tissue-isolated
hepatomas appears to depend on the normal, nearly constant
flow in the sup. inf. epigastric artery. Consequently, larger
tumours have a lower blood flow rate per unit mass
(ml min'l g'i tumour) than smaller tumours. Similar passive
tumour venous blood flow rates were observed by Kallinow-
ski et al. (1989) during arterioenous difference measurements
across tissue-isolated human tumour xenografts growing on
the sup. inf. epigastric artery of nude rats. These authors also
observed, however, that the rate ofpassive venous flow was a
function of the tumour type. pH, P02 and pCO2 (n = 12)
were 7.41 ± 0.06, and 88.8 ± 11.4 and 27.4 ± 7.2 mm Hg in
host arterial blood, respectively, and 7.35 ± 0.05, and
23.8 ± 8.9 and 49.6 ± 6.2 mm Hg in tumour venous blood,
respectively. Similar differences in hematocrit, pH and blood
gases were observed across tissue-isolated human tumour
xenografts in vivo in nude rats (Kallinowski et al., 1989).
Arterialplasma lipids
Diurnal rhythms in amounts of arterial blood plasma lipids
were observed in tumour-bearing Buffalo rats (Figure 1). The
sums of myristic, palmitic, palmitoleic, stearic, oleic, linoleic
and arachidonic acids contained in FFA, TGA, PL and CE
were low during the light period and increased between 1600
to 2000h with onset of darkness. Plasma lipid fatty acid
contents measured at 1600 h were significantly less (P<0.05)
than those measured at 2200 h. The content of plasma FFAs
showed a second, small increase during mid-day. Diurnal
variations in blood lipid concentrations resulted from in-
creased feeding during the dark period (Fuller & Diller,
1970). Areas under the curves shown in Figure 1 were cal-
culated using the trapezoidal rule (Courant, 1937), which
estimated mean values over the 24 h period of 163, 590, 482
and 97jig fatty acid ml-' whole arterial blood for FFA, PL,
TGA and CE, respectively.
Despite the large diurnal variation in plasma lipid content,
the fatty acid compositions of individual arterial blood
plasma lipids were remarkably constant (Table I). Plasma
FFA and TGA were good sources of oleic, palmitic and
linoleic acids. FFA (but not TGA) also contained substantial
amounts of arachidonic acid. Stearic, arachidonic, palmitic
and linoleic acids comprised over 90% of the fatty acid
content of plasma PL, the most abundant arterial plasma
lipid. Stearic acid was higher in PL than in any other plasma
lipid. Although CE was the least abundant plasma lipid, it
was a good source of arachidonic and linoleic acids.
Uptake ofarterialplasma lipids
The relationships between supply of myristic, palmitic, pal-
mitoleic, stearic, oleic, linoleic and arachidonic acids in FFA,
TGA, PL and CE and uptake by hepatomas 7288CTC and
7777 in vivo are shown in Figure 2. Fatty acid uptake was
directly dependent on the rate of supply of the lipid. As
judged from the regression lines, hepatoma 7288CTC
removed 46.2, 36.0, 32.6 and 31.4% and hepatoma 7777
removed 47.7, 52.4, 50.0 and 48.6% of the seven fatty acids
contained in FFA, PL, TGA and CE, respectively, during
one pass of arterial blood. Uptake of individual fatty acids
depended on the lipid supply to the tumour and on the fatty
acid composition of the lipid. For example, stearic acid is a
major constituent of PL and uptake of stearate from PL
occurred at a substantial rate, especially during the dark
period. It cannot be decided from these data if the intact
TGA, PL or CE molecule was taken up by the tumour or if
the fatty acids were first released and then accumulated.
Arteriovenous difference measurements performed in cou-
madin-treated rats were not different from measurements
made in rats anticoagulated with heparin and the data were
combined; heparin-treatment did not modify tumour lipid
uptake.
Perfusion in situ
Perfusion of hepatoma 7288CTC in situ with donor blood
containing '4C-palmitic acid showed that the uptake ofTUMOUR LIPID UPTAKE IN VIVO 293
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Figure 1 Diurnal changes in the plasma lipid concentrations in arterial blood ofhepatoma 7288CTC-bearing rats fed normal chow
ad libitum. Animals were subjected to darkness from 1800 to 0600 h. Values expressed as mg fatty acids ml-' whole blood are the
sums of myristic, palmitic, palmitoleic, stearic, oleic, linoleic and arachidonic acids in the different plasma lipid classes (as
indicated) collected at the different time points. Estimated mean values over the 24 h period were 163, 590, 482, and 97 lg ml'
arterial blood for FFA, PL, TGA and CE, respectively. Each point represents the mean + s.d., n = 72 for FFA measurements and
n = 18 for TGA, PL and CE measurements.
Table I Plasma lipid fatty acid composition in adult tumour-bearing
Buffalo rats
% of Total (mean ± s.d.)
Fatty acid FFA TGA PL CE
C14:0 1.3±0.3 1.0±0.2 0.3±0.1 1.0±0.3
C16:0 21.6 1.4 26.3 1.5 20.0±0.9 8.9±0.9
C16:1 3.7±0.7 3.4±0.8 0.6±0.2 3.2±2.9
C18:0 7.6± 1.5 6.5±0.7 26.7± 1.8 3.5± 1.0
C18:1 28.8±2.4 34.4±2.5 8.1±1.3 11.1±1.2
C18:2 21.6 1.6 24.0 3.5 19.9 1.8 20.0 2.5
C20:4 15.4 ± 2.7 4.0 ± 1.1 24.5 ± 2.3 53.6 ± 3.2
n = 72 n= 18 n= 18 n= 18
weight, respectively, and were not significantly different.
Fatty acid compositions of TGAs in tumours (Table III)
and plasma (Table I) were similar; oleic, the most abundant
fatty acid, was followed in amount by palmitic and linoleic
acids. The arachidonic acid content of tumour and plasma
TGAs was low even though arachidonate was a major con-
stitutent of plasma FFAs. Fatty acid contents of tumour and
plasma PLs were similar, except that oleic acid formed nearly
28% of tumour PLs but only about 8% of plasma PLs.
Palmitic and stearic acids and the essential fatty acids were
major constituents of both plasma and tumour PLs.
Discussion
labelled palmitate occurred to the same extent as did uptake
of total palmitate (Table II). About 50% of the palmitic acid
in the arterial blood was removed by the tumour when
measured at both 30 and 60 min after start of the perfusion.
The specific activity of "4C-palmitic acid in arterial and
tumour venous blood was identical, indicating that both
labelled and unlabelled palmitate were utilised simul-
taneously. Total estimated tumour uptake of (1-'4C)palmitic
acid (based on arteriovenous difference measurements) was
15240 d.p.m. g-' tumour. This value compared favorably
with the '4C-content of the tumour measured at the end of
the perfusion (16500 d.p.m. g-', about equally distributed
among TGA, PL and FFA). A small amount of 14CO2 was
released into the tumour venous blood. However, the rate of
'4CO2 production increased during the perfusion suggesting
that a steady state of '4C-oxidation may not have been
reached. The '4CO2 production rate at the end of the per-
fusion was 8 d.p.m. min-' g-' or about 3% of the rate of
tumour (1-'4C)palmitic acid uptake (254 d.p.m. min-' g-).
Tumourfatty acid content
The myristic, palmitic, palmitoleic, stearic, oleic, linoleic and
arachidonic acid contents in TGA, PL and CE of the
tumours used in the arteriovenous difference measurements
shown in Figure 2 are listed in Table III. TGAs, PLs and
CEs in hepatomas 7288CTC and 7777 were essentially iden-
tical in fatty acid composition and similar in content. Total
contents of the seven fatty acids in hepatomas 7288CTC and
7777 were 13.4 ± 2.5 and 10.5 ± 4.0 mg g- tumour wet
These experiments were a continuation of our studies of
nutrient supply and uptake in solid tumours in vivo (Sauer &
Dauchy, 1982; 1983). Lipids are essential cellular constituents
and a steady supply is needed for growth of tumour mass.
The central role of lipids in tumour metabolism was
emphasised by nutritional experiments (Ip et al., 1985) show-
ing that dietary lipids, notably those that contain linoleic
acid, have stimulative effects on tumour growth. These
growth effects are probably separate from the need for lipids
in formation of cell structures. Recently, we showed that the
rates of growth of three Morris hepatomas and two other rat
tumours were increased during acute starvation (Sauer et al.,
1986) and streptozotocin-induced diabetes (Sauer & Dauchy,
1987). Subsequent experiments demonstrated that the growth
stimulus was caused by lipid substances contained in hyper-
lipemic blood and released from host fat stores (Sauer &
Dauchy, 1987; 1987a). The lipids were identified as free
linoleic and arachidonic acids (Sauer & Dauchy, 1988).
Tumour FFA uptake and rate of 3H-thymidine incorporation
appeared to be very sensitive to the ambient concentration of
essential fatty acids in arterial blood. However, there were no
data on lipid supply and uptake and on the properties of
lipid uptake in solid tumours in vivo. Results reported here
show that about 50% of the blood FFAs and 30 to 50%
(depending on the tumour) of the other plasma lipids were
removed during one pass of arterial blood. As was shown in
Figure 2, lipid uptake by tumours in vivo is very dependent
on the rate of supply in arterial blood. Since the effects of
linoleate and arachidonate on tumour 3H-thymidine incor-
poration have a short half-life (Sauer & Dauchy, 1988), these
observations provide a reasonable basis for understanding
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Figure 2 Relationships between supply in the arterial blood and tumour uptake of free fatty acids, phospholipids, triglycerides and
cholesterol esters by hepatomas 7288CTC and 7777. Values for rates of supply and uptake are for individual fatty acids from the
different lipid classes, as follows: 0, myristic; A, palmitic; 0, palmitoleic; V, stearic; *, oleic; A, linoleic; and, * arachidonic
acids. Correlation coefficients from regression analysis for hepatoma 7288CTC were: free fatty acids, 0.901; phospholipids, 0.932;
triglycerides, 0.784; cholesterol esters, 0.969; and for hepatoma 7777 were: free fatty acids, 0.905; phospholipids, 0.978; triglycerides,
0.904; cholesterol esters, 0.985. Each point represents a measurement made on a single tumour.
Table II Supply and uptake of arterial blood free [1-'4C]-palmitic acid in hepatoma 7288CTC perfused in situ
[I-`Cj-Palmitic acid C02
Specific
Perfusion Content Content activity Supply Uptake Content Release
time Tissue ILgml-' d.p.m. ml-' d.p.m.fLg-'] tgmin-'g-' figmin-'g-' d.p.m. ml-' d.p.m. min-' g-'
30 min A 88.7 17114 193 2.65 31
V 49.1 9780 199 1.32 190 4
60 min A 90.8 17114 189 2.69 9
V 50.8 9492 187 1.33 319 8
T 1.38a 16500b 12C
A = arterialblood; V = tumour venousblood; T = tumour; amgpalmitic acid g- ;bd.p.m. g- ;cassumesallradioactivity isinpalmitic
acid. Total tumour '4C-palmitic acid uptake from the arterial blood was 15300 d.p.m. g-' (rate ofuptake times specific activity times
60min)andtotal tumour 14C-contentwas 16500 d.p.m. g- . Recoverywas: content/uptake (100) = 108%. Thetumourweightwas4.62 g
andarterialandtumourvenousbloodflowwas0.138 and0.125 ml min , respectively. The 14C-palmiticacidconcentration inthearterial
blood perfusate was 0.35 mm.
how changes in host blood lipid levels could have immediate
effects on tumour metabolism. In a companion paper (Sauer
& Dauchy, 1992), we show that increased ambient levels of
linoleic and arachidonic acids in arterial blood increase the
rate of tumour 3H-thymidine incorporation, thus providing
further evidence linking supply and uptake to biochemical
growth processes. It is not yet known if essential fatty acids
supplied in TGA, PL and CE also have a stimulative effect
on tumour 3H-thymidine incorporation and growth rate.
Presumably, they do not, because perfusion of hepatoma
7288CTC in situ with fractions from hyperlipemic blood that
contained these lipids did not affect tumour 3H-thymidine
incorporation (Sauer & Dauchy, 1988).
It has been known for several years that tumour cells
utilise FFAs in vitro (Fillerup et al., 1958). Mouse ascites
tumour cells have been a convenient model for study in vitro
and in vivo. Recent experiments have demonstrated uptake of
FFAs from ascites plasma by mouse ascites tumour cells in
vivo (Spector, 1967; Mermier & Baker, 1974). Uptake of
'4C-palmitate by these cells in vitro was increased as the
FFA-albumin ratio was increased. The radiolabelled pal-
mitate was incorporated into tumour cell TGA, PL and CO2
m
0
E
+-
0)
._
a) 3
2TUMOUR LIPID UPTAKE IN VIVO 295
Table III Fatty acid composition and lipid content of hepatomas 7288CTC and 7777
7288CTC (mean ± s.d., n = 6) 7777 (mean ± s.d., n = 9)
Fatty TGA PL CE Total TGA PL CE Total
acid Ag g-I Ztgg-I'g g-I gg g_I
C14:0 72 ± 60 36 ± 16 20 ± 14 138 ± 81 60 ± 52 57 +27 9 7 115 91
C16:0 1024 ± 648 1090 ± 272 31 ± 23 2124 ± 731 635 ± 501 1024 327 43 15 1827 945
C16:1 304 ± 179 370 ± 120 7 ± 7 736 ± 133 176 ± 120 253 84 5 8 495 140
C18:0 406 ± 147 1895 ± 409 25 ± 10 2032 ± 388 342 157 1393 285 39 20 1848 545
C18:1 2381 ± 1183 2601 ± 669 26 ± 16 5104 ± 1192 1472 995 1661 312 60 38 3627 1531
C18:2 898 ± 527 975 ± 238 26 ± 27 1837 ± 564 492 349 721 188 26 10 1333 652
C20:4 196 ± 156 1209 ± 219 36 ± 11 1413 ± 568 242 140 913 231 37 34 1293 381
Total 5280±2553 8176± 1883 13386±2536a 3419±2164 6015± 1176 10538±4055a
ap>0.05.
(Spector & Brenneman, 1973). As shown in Table II, a
similar result was observed in hepatoma 7288CTC perfused
in situ with '4C-palmitate. Mouse ascites tumour cells in vitro
also utilised radiolabelled TGAs contained in ascites plasma
lipoproteins (Brenneman & Spector, 1974). Fatty acid uptake
from lipoprotein TGAs appeared to depend on the
availability of the TGAs in ascites plasma and may have
occurred as the intact TGA molecule. While our experiments
were not designed to directly examine the latter point, we
found that host arterial blood TGAs, as well as PLs and
CEs, were good lipid sources for solid tumours in vivo.
Similar fatty acid compositions in plasma (Table I) and
hepatoma (Table III) TGAs suggest that these molecules
might have traversed the cell membrane as intact TGA
molecules. Although solid tumours in vivo are perfused with
blood and mouse ascites tumour cells in vivo are bathed in
ascites plasma, indicating much different rates oflipid supply,
the overall properties of lipid uptake appear to be similar.
Experiments performed in culture with hepatoma 7288C
cells indicated that more than 80% of the fatty acids required
for growth were obtained from the medium (Watson, 1973).
The fatty acid composition of PLs in hepatoma 7288CTC in
vivo were modified by changes in dietary fat (Wood, 1975),
further evidence of tumour access to circulating host lipids.
Hepatomas 7288CTC and 7777 grow at a rate of about
1 g day-' (Sauer et al., 1980; 1986) in Buffalo rats fed a
normal diet ad libitum. Therefore, the amount of the 7 fatty
acids required for the 1 g day-' growth increment was
13.4 ± 2.5 mg day-' in hepatoma 7288CTC and 10.6 ± 3.9-
mg day-' in hepatoma 7777 (Table III). To determine if fatty
acid uptake from plasma lipids was sufficient to satisfy these
growth requirements in vivo, we compared the values to the
calculated daily total fatty acid uptake (mg fatty acid-
day-' g-'). Daily fatty acid uptake for the 15 tumours
examined was calculated as follows: [arterial blood flow rate
(ml min-')] times [mean arterial blood fatty acid content for
each lipid class (data from legend to Figure 1) over the 24 h
period (mg ml-l arterial blood)] times [1440 min day-']
divided by [wet weight of the hepatoma (g)] times [the mean
efficiency of tumour uptake of the lipid supplied (from legend
to Figure 2)]. We assume in these calculations that tumour
blood flow and efficiencies of lipid uptake are constant
through the 24 h. The calculated rate of uptake (hepatoma
7288CTC, 18.1 mg day-' g-'; hepatoma 7777, 25.9 mg day-'
g-1) was divided by the tumour fatty acid growth increment
(mg day-' g-1). The result suggested that uptake of fatty
acids from blood lipids was 138 ± 22% (n = 6) in hepatoma
7288CTC and 280 ± 121% (n = 9) in hepatoma 7777 of the
amount needed for daily growth. Since rates of fatty acid
oxidation are low in hepatoma 7288CTC (Table II) and 7777
(Halperin et al., 1975), these data indicate that both
hepatomas obtain most or all of the fatty acids needed for
growth from host arterial blood lipids.
The relationship between daily oleic acid uptake and the
oleic acid growth increment in hepatoma 7288CTC is of
interest because this tumour contains large amounts of oleic
acid (Table III) but shows decreased levels of stearoyl-CoA
desaturase, compared to normal liver (Zoeller & Wood,
1984). It was suggested that most of the oleic acid contained
in hepatoma 7288CTC may be derived from the host sources
(Zoeller & Wood, 1984). Mean uptake of oleic acid from
blood lipids by hepatoma 7288CTC was 3.8 ± 0.8 mgg-' or
75 ± 12% of the increment needed for daily growth. Mean
uptake of stearic acid was 2.7 ± 0.5 mg day-' or 139 ± 24%
of the daily stearate requirement. The short fall in oleate
uptake was 1.3 ± 0.7 mg day-' and the stearate uptake excess
was 0.7 ± 0.4 mg day-'. Thus, a portion of the oleate defic-
iency may have been recovered from the excess stearate
uptake via stearoyl-CoA desaturase. Presumably, the
remainder was generated from other fatty acids that were
also taken up in excess. It should be remembered, however,
that solid tumours contain populations of host cells: accurate
assessment of an excess or deficiency would require detailed
knowledge of the biosynthetic capabilities of each cell type
and their abilities to communicate.
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References
BECK, S.A. & TISDALE, M.J. (1987). Production of lipolytic and
proteolytic factors by a murine tumor-producing cachexia in the
host. Cancer Res., 47, 5919-5923.
BECK, S.A. & TISDALE, M.J. (1991). Lipid mobilizing factors
specifically associated with cancer cachexia. Br. J. Cancer, 63,
846-850.
BRENNEMAN, D.E. & SPECTOR, A.A. (1974). Utilization of ascites
plasma very low density lipoprotein triglycerides by Ehrlich cells.
J. Lipid Res., 15, 309-316.
COURANT, R. (1937). Differential and Integral Calculus. Vol. I,
p. 343. Interscience Publishers, Inc.: New York.
DAUCHY, R.T. & SAUER, L.A. (1986). Preparation of 'tissue-isolated'
rat tumors for perfusion: A new surgical technique that preserves
continuous blood flow. Lab. Animal Sci., 36, 678-681.
FILLERUP, D.L., MIGLIORI, J.C. & MEAD, J.F. (1958). The uptake of
lipoproteins by ascites tumor cells. The fatty acid-albumin com-
plex. J. Biol. Chem., 233, 98-101.
FOLCH, J., LEES, M. & SLOANE-STANLEY, G.H. (1957). A simple
method for the isolation and purification of total lipids from
animal tissues. J. Biol. Chem., 226, 497-507.
FULLER, R.W. & DILLER, E.R. (1970). Diurnal variation of liver
glycogen and plasma free fatty acids in rats fed ad libitum or a
single daily meal. Metabolism, 19, 226-229.
GULLINO, P.M. & GRANTHAM, F.H. (1961). Studies on the exchange
of fluids between host and tumor. 1. A method for growing
'tissue-isolated' tumors in laboratory animals. J. Natl Cancer
Inst., 27, 679-693.296 L.A. SAUER & R.T. DAUCHY
GULLINO, P.M., GRANTHAM, F.H. & COURTNEY, A.H. (1967).
Glucose consumption by transplanted tumors in vivo. Cancer
Res., 27, 1031-1040.
HALPERIN, M.L., TAYLOR, W.M., CHEEMA-DHADLI, S., MORRIS,
H.P. & FRITZ, I.B. (1975). Effects of fasting on the control of
fatty-acid synthesis in hepatoma 7777 and host liver. Eur. J.
Biochem., 50, 517-522.
IP, C., CARTER, C.A. & IP, M.M. (1985). Requirement for essential
fatty acid for mammary tumorigenesis in the rat. Cancer Res., 45,
1997-2001.
KALLINOWSKI, F., VAUPEL, P., RUNKEL, S., FORTMEYER, H.P.,
BAESSLER, K.H., WAGNER, K., MUELLER-KLIESER, W. &
WALENTA, S. (1988). Glucose uptake, lactate release, ketone
body turnover, metabolic micromileau and pH distributions in
human breast tumor xenografts in nude rats. Cancer Res., 48,
7264-7272.
KALLINOWSKI, F., SCHLENGER, K.H., KLOES, M., STOHRER, M. &
VAUPEL, P. (1989). Tumor blood flow: The principal modulator
of oxidative and glycolytic metabolism and of the metabolic
micromileau of human tumor xenografts in vivo. Cancer, 44,
266-272.
MCDONALD-GIBSON, R.G. (1987). Quantitative measurements of
arachidonic acid in tissues or fluids. In Prostaglandins and
Related Substances, Benedetto, C., McDonald-Gibson, R.G.,
Nigam, S. & Slater, T.F. (eds) p. 259-268. IRL Press: Washing-
ton.
MERMIER, P. & BAKER, N. (1974). Flux of free fatty acids among
host tissue, ascites fluid, and Ehrlich ascites carcinoma cells. J.
Lipid Res., 15, 339-351.
SAUER, L.A., DAUCHY, R.T., NAGEL, W.O. & MORRIS, H.P. (1980).
Mitochondrial malic enzymes. J. Biol. Chem., 255, 3844-3848.
SAUER, L.A., STAYMAN, J.W. & DAUCHY, R.T. (1982). Amino acid,
glucose and lactic acid utilization in vivo by rat tumors. Cancer
Res., 42, 4090-4097.
SAUER, L.A. & DAUCHY, R.T. (1983). Ketone body, glucose, lactic
acid and amino acid utilization by tumors in vivo in fasted rats.
Cancer Res., 43, 3497-3503.
SAUER, L.A., NAGEL, W.O., DAUCHY, R.T., MICELI, L.A. & AUSTIN,
J. (1986). Stimulation of tumor growth in adult rats in vivo during
an acute fast. Cancer Res., 46, 3469-3475.
SAUER, L.A. & DAUCHY, R.T. (1987). Stimulation of tumor growth
in adult rats in vivo during acute streptozotocin-induced diabetes.
Cancer Res., 47, 1756-1761.
SAUER, L.A. & DAUCHY, R.T. (1987a). Blood nutrient concentrations
and tumor growth in vivo in rats; Relationships during the onset
of an acute fast. Cancer Res., 47, 1065-1068.
SAUER, L.A. & DAUCHY, R.T. (1988). Identification of linoleic and
arachidonic acids as the factors in hyperlipemic blood that in-
creases 3H-thymidine incorporation in hepatoma 7288CTC per-
fused in situ. Cancer Res., 48, 3106-3111.
SAUER, L.A. & DAUCHY, R.T. (1992). The effect of omega-6 and
omega-3 fatty acids on 3H-thymidine incorporation in hepatoma
7288CTC perfused in situ. Br. J. Cancer, 66, 297-303.
SPECTOR, A.A. (1967). The importance of free fatty acids in tumor
nutrition. Cancer Res., 27, 1580-1586.
SPECTOR, A.A. & BRENNEMAN, D.E. (1973). Role of free fatty acid
and lipoproteins in the lipid nutrition of tumor cells. In Tumor
Lipids; Biochemistry and Metabolism, Wood, R. (ed.) p. 1-13.
American Oil Chemists Society: Champaign.
STEINAU, H.U., BASTERT, G., EICHHOLZ, H., FORTMEYER, H.P. &
SCHMIDT-MATTHIESEN, H. (1981). Epigastric pouching techni-
que: Human xenografts in mu/rnu rats. In Thymusaplastic Nude
Mice and Rats in Clinical Oncology, Bastert, G.B.A., Fortmeyer,
H.P. & Schmidt-Matthiessen, H. (eds) p. 531-542. Gustav Fis-
cher Verlag: Stuttgart.
WATSON, J.A. (1973). Regulation of cholesterol synthesis in HTC
cells (minimal deviation hepatoma 7288CTC). In Tumor Lipids:
Biochemistry and Metabolism, Wood, R. (ed.) p. 34-53. Ameri-
can Oil Chemists Society: Champaign.
WEBER, G., MORRIS, H.P., LOVE, W.C. & ASHMORE, J. (1961). Com-
parative biochemistry of hepatomas. II. Isotope studies of car-
bohydrate metabolism in Morris hepatoma 5123. Cancer Res., 21,
1406-1411.
WOOD, R. (1975). Hepatoma, host liver and normal rat liver as
affected by diet. Lipids, 10, 736-745.
ZOELLER, R.A. & WOOD, R. (1984). Analysis of the stearoyl-CoA
desaturase system in the Morris hepatoma 7288C and 7288CTC.
Lipids, 19, 488-491.